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Employment Opportunities
Faculty, Department of Genetic Counseling.—A faculty po-
sition is available in the Department of Genetic Counsel-
ing, which offers a master’s degree in genetic counseling
through the College of Health Related Professions and the
Graduate School at University of Arkansas for Medical Sci-
ences (UAMS). UAMS is the leading institution in theMid-
America Genetic Education Consortium (MAGEC), which
includes the University of Oklahoma Health Science Cen-
ter, the University of Nebraska Medical Center, and the
University of Kansas KU Medical Center. This unique pro-
gram combines the academic and clinical resources of four
major health science universities by use of distance edu-
cation and Web-based technologies. The faculty member
will be responsible for developing Web-based coursework
and for providing instruction of that coursework, depart-
mental development activities, research collaboration,
and service, both internally within the University and ex-
ternally to the profession and community at large. Salary
and academic rank for this tenure-track position will be
commensurate with qualiﬁcations. The minimum quali-
ﬁcations are (1) either a master’s degree in genetic coun-
seling or a related area and certiﬁcation by the American
Board of Genetic Counseling (ABGC) in genetic counsel-
ing or a doctoral degree and certiﬁcation by the American
Board of Medical Genetics (ABMG), (2) good computer
literacy and technology skills, (3) willingness and ability
to learn new technologies and skills as needed to provide
Web-based distance education, (4) at least 2 years of clin-
ical experience, and (5) prior teaching experience. Pre-
ferred qualiﬁcations include experience in genetic coun-
selor education, with distance education, with Web-based
distance learning software, and working within an ABGC-
accredited genetic counseling program. Review of appli-
cants will begin March 5, 2007, and will continue until
the position is ﬁlled. Applications should include a letter
of interest, a current curriculum vitae, and the names and
contact information for ﬁve professional references. At
least one of the references should be from a previous stu-
dent. Little Rock, the capital of Arkansas, is a progressive
city with excellent quality of life. Little Rock offers a down-
town convention and entertainment district, a ﬁne sym-
phony orchestra, restaurants, theater, shopping, muse-
ums, and the new William J. Clinton Presidential Center.
Little Rock is located on the beautiful Arkansas River and
has plentiful hiking, cycling, camping, ﬁshing, and boat-
ing opportunities nearby. The climate is temperate, allow-
ing for outdoor activities year round. For more informa-
tion, see Little Rock’s Web site (http://www.littlerock
.com/). To apply, send materials to Bruce R. Haas, M.S.,
CGC, Chairman, Department of Genetic Counseling,
Search Committee Chairman, College of Health Related
Professions, University of Arkansas for Medical Sciences,
4301 W. Markham Street, #836, Little Rock, AR 72205;
telephone: (501) 526-7700; fax: (501) 526-7711; e-mail:
brhaas@uams.edu. E-mail submission of applications
is encouraged. For more complete information, visit
the Department’s Web site (http://www.uams.edu/chrp/
genetics/). UAMS is an afﬁrmative action/equal opportu-
nity employer.
Academic Clinical Cytogeneticist.—The Department of Pa-
thology at Beth Israel Deaconess Medical Center is seeking
to recruit a full-time clinical cytogeneticist. The candidate
must hold M.D. and/or Ph.D. degrees and must have ap-
propriate board certiﬁcation. The position offers an ex-
ceptional opportunity to work with a premier group of
academic cytogeneticists within the Harvard Longwood
Medical area, managing a comprehensive laboratory with
cutting-edge technology and supporting active clinical
and research programs in hematological malignancy,
bone marrow transplantation, obstetrics, and neonatol-
ogy. Beth Israel Deaconess Medical Center is a 523-bed
tertiary care facility and a principal teaching hospital of
Harvard Medical School. Our clinical laboratories perform
16,700,000 tests annually. The Department of Pathology
is currently engaged in an ambitious effort to recruit new
clinical and research faculty. We have also begun a com-
plete renovation of our physical facilities to create a state-
of-the-art clinical laboratory infrastructure, includingded-
icated research space for clinical faculty. These plans
include a new cytogenetics laboratory, which the suc-
cessful candidate will play a major role in designing and
equipping. We also intend to hire new technical and ad-
ministrative staff to support the laboratory.We are seeking
an outstanding clinical cytogeneticist who shares our vi-
sion of excellence in academic pathology. In addition to
taking on clinical and administrative service responsibil-
ities, the successful candidate will be expected to play an
active role in our pathology training program and to de-
velop a strong program in basic, applied, or translational
research related to cytogenetics. The position includes a
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faculty appointment at Harvard Medical School at an ac-
ademic rank commensurate with experience. Interested
applicants should submit a curriculumvitae and three pro-
fessional references to Lynne Uhl, M.D., Director, Division
of Laboratory and Transfusion Medicine, Beth Israel Dea-
coness Medical Center, 330 Brookline Avenue, Boston,MA
02215; e-mail:luhl@bidmc.harvard.edu
Postdoctoral Positions in Human Evolutionary Genomics.—
Postdoctoral positions are available in a human popula-
tion genetics laboratory in the Department of Biology at
the University of Maryland at College Park (UMCP). Pro-
jects in the lab focus on a unique resource of DNA samples
from a large set of ethnically and geographically diverse
African populations. These samples are being used for ge-
nome-level analyses of diversity at both coding and non-
coding loci. For many of these samples, we also have phe-
notype data for a number of traits that are likely important
in adaptation, including those with a complex pattern of
inheritance. We are using these data (1) to infer popula-
tion structure and demographic history and to testmodels
of modern human evolution; (2) to identify regions of the
genome that are targets of selection, by use of whole-
genome scans; (3) to identify functionally signiﬁcant var-
iants, by use of genotype/phenotype association studies
as well as gene-expression analyses; and (4) to study the
genetic basis of resistance against infectious disease (with
a focus on malaria) and coevolution of the human and
Plasmodium falciparum genomes. UMCP is located in a
suburb of Washington D.C. with easy access to a num-
ber of research institutions in the Baltimore/D.C. area,
including the National Institutes of Health, the Smith-
sonian, The Institute for Genomic Research, George
Washington University, and Johns Hopkins University.
Candidates with a strong molecular and/or statistical ge-
netics background are encouraged to apply. Familiarity
with population genetics theory and/or computer pro-
gramming is a plus. Salaries are commensurate with qual-
iﬁcations and experience. For additional information,
see the laboratory’s Web site (http://www.life.umd.edu/
biology/tishkofﬂab/). Applicants should send a curriculum
vitae, a statement of interest, and contact information for
three references to Dr. Sarah Tishkoff, Department of Bi-
ology, Biology/Psychology Building #144, University of
Maryland, College Park, MD 20742; e-mail: tishkoff@
umd.edu. The University of Maryland is an equal oppor-
tunity/afﬁrmative action employer.
Clinical Geneticist.—The Department of Medicine of Ev-
anston Northwestern Healthcare (ENH), a major teaching
afﬁliate of Northwestern University’s Feinberg School of
Medicine (NUFSM), seeks a full-time clinical geneticist.
Candidates with an M.D., M.D./Ph.D., or D.O. should be
board certiﬁed by the American Board of Internal Medi-
cine in internal medicine and should be board certiﬁed
or board eligible in medical genetics. ENH has a large fac-
ulty practice plan numbering close to 500 physicians and
also has a strong research institute with an annual budget
of close to 35 million dollars per year. The Center for Med-
ical Genetics employs four certiﬁed genetic counselors,
has an annual volume of 750 patient visits, and is growing
at a rate of 25%. The successful applicant will have op-
portunities for laboratory and clinical research in cancer
genetics and genomic medicine. The candidate should
be eligible for an appointment as an Assistant Professor
on a clinician/investigator, nontenure track. NUFSM and
ENH are afﬁrmative action, equal opportunity employers.
Compensation will be commensurate with experience. A
mutually convenient anticipated starting date will be ar-
ranged. Minorities are encouraged to apply. Hiring is con-
tingent upon eligibility to work in the U.S., Search # P-
247N-07. Please send a curriculum vitae and reply by June
15, 2007, to Boris Pasche, M.D., Ph.D., Associate Professor,
Department of Medicine, Division of Hematology Oncol-
ogy, 676 North St. Clair Street, #850, CHHNMH, Chicago,
Illinois 60611; fax: (312) 503-2513; e-mail: b-pasche@
northwestern.edu
Clinical Cytogeneticist.—The Department of Pathology and
Laboratory Medicine at Vancouver Acute, part of Van-
couver Coastal Health Authority (VCHA), is seeking a full-
time clinical cytogeneticist to join the team of the Cy-
togenetics Laboratory. This state-of-the-art laboratory
provides cytogenetics and molecular cytogenetics support
for the British Columbia Bone Marrow Transplantation/
Leukemia program, as well as prenatal and adult consti-
tutional cytogenetic analyses. Clinical responsibilities in-
clude shared coverage with triage, review, interpretation,
reporting, and consultation of bone marrow, amniotic
ﬂuid, and constitutional blood specimens, as well as par-
ticipation in the laboratory quality assurance program,
administrative duties, and development and monitoring
of assay protocols. The successful candidate will also
have a cross appointment with the University of British
Columbia (UBC) Department of Pathology andLaboratory
Medicine, including teaching responsibilities for fellows,
residents, and undergraduate students as well as oppor-
tunities for clinical research. The candidate should hold a
Ph.D. degree and should be certiﬁed/eligible in clinical
cytogenetics by the Canadian College of Medical Genet-
icists (CCMG). CCMG certiﬁcation in molecular genetics
is an asset. Salary will be commensurate with qualiﬁcation
and experience. VCHA and UBC hire on the basis of merit
and are committed to employment equity. We encourage
all qualiﬁed persons to apply. In accordance with Cana-
dian Immigration requirements, priority will be given to
Canadian citizens and permanent residents of Canada.
The search will be ongoing until a suitable candidate is
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identiﬁed. A letter of interest and the names of three ref-
erences should be submitted with a current curriculum
vitae to Dr. He´le`ne Bruye`re, Director, Cytogenetics Labo-
ratory, Department of Pathology and Laboratory Medi-
cine, Vancouver General Hospital, 855 West 12th Ave-
nue, Vancouver, BC, Canada V5Z 1M9; e-mail: helene
.bruyere@vch.ca
Meeting
Society of Craniofacial Genetics Annual Meeting and Sympo-
sium.—The Society of Craniofacial Genetics will hold its
30th Annual Meeting and Symposium in conjunctionwith
the American Society of Human Genetics Meeting in San
Diego, CA, on Tuesday, October 23, 2007. Abstracts for
presentation at the meeting are invited and should be
sent as PDF attachments to the President of the Society
(jhelms@stanford.edu). Details of the meeting can be ac-
cessed on the Society’s Web site (http://craniofacialgenetics
.org/).
Conferences
British Human Genetics Conference.—The British Human
Genetics Conference will be held at the University of York
in the United Kingdom on September 17-19, 2007. The
scientiﬁc programme for the conference will be as follows.
On Monday, September 17, symposia will be held on “De-
velopmental and Paediatric Genetics” (Dr. Ian Krantz,
Philadelphia; Dr. Brunella Franco, Naples, Italy; and Dr.
Eric Legius, Leuven, Belgium), “Genomic/RNA” (Prof. Neil
Aronin, Massachusetts, and Dr. David Nelson, Houston),
and “Counseling/Ethics” (Dr. Helen Wall, London; Ms.
Jane Fisher, London; and Prof. Julian Savulescu, Oxford).
A debate will also be held on “The Ups and Downs of
Gene Databanks” (Prof. Marcus Pembrey, Bristol; Prof.
Paul Martin, Nottingham; Dr. Michael Barr, Newcastle;
and Prof. Steven Bain, Swansea). On Tuesday, September
18, symposia will be held on “Mechanisms of Disease/
Cardiovascular” (Dr. Hall Dietz, Baltimore; Prof. Christine
Seidman, Boston; and Dr. Francesco Muntoni, London)
and “Interphase, Networks, and Evolution” (Prof. Uwe
Claussen, Jena, Germany; Prof.MarianoRocchi, Bari, Italy;
and Prof. Job Dekker, Worcester, MA). A workshop on
“Communicating and Managing Risk” will also be held
(Prof. Gareth Evans, Manchester; Dr. Usha Menon, UCLH;
Prof. Sue Michie, UCH; Prof. Scott Campbell, Nottingham;
and Prof. Theresa Marteau, London). The Carter Lecture
on “The Role of Human Genetics in Our Understanding
on How Genes Are Switched On and Off” will given by
Professor Doug Higgs (Oxford). OnWednesday, September
19, symposia will be held on “Complex Disease Genetics”
(Prof. Doug Easton, Cambridge; Prof. Tim Aitman, Lon-
don; and Dr. Rob Sladek, Quebec), “Fusions, Transloca-
tions, and Databases” (Prof. Terry Rabbitts, Leeds; Prof.
Felix Mitelman, Lund, Sweden; and Prof. Ollie-P Kallion-
iemi, Turku, Finland), and “Mechanisms of Disease II”
(Prof. John McGrath, KLC; Prof. Craig Basson, New York;
and Dr. Susan Hayﬂick, Portland, OR). Workshops will
be held on “National Genetic Reference Laboratories—
Achievements and Plans” (participants to be announced);
“Consanguinity and Genetic Disorders” (Prof. Richard
Trembath, London; Dr. Alison Shaw, Oxford; Dr. Lihadh
Al-Gazali, Abu Dhabi; Dr. Andrew Jackson, Edinburgh; Dr.
Irene Aligianis, Birmingham; Dr. Yanick Crow, Leeds; Dr.
Louise Brueton, Birmingham; and Dr. Saddaf Farooqi,
Cambridge; Prof. Eamonn Maher, Birmingham), and “Ge-
netics of Lymphoma and Solid Tumors” (Prof. Reiner Sie-
bert, Kiel, Germany; Dr. Janet Shipley, Sutton, Surrey; and
Karen Sisley, Shefﬁeld). Additional participantsmay be an-
nounced for some of these events. Further information is
available from The Conference Ofﬁce, British Society for
Human Genetics, Clinical Genetics Unit, Birmingham
Women’s Hospital, Edgbaston, Birmingham B15 2TG,
United Kingdom; telephone: 0121 627 2634; fax: 0121
623 6971; e-mail: york2007@bshg.org.uk; Web: (http://
www.bshg.org.uk/york2007.htm). Registered Charity No.
1058821.
International Conference on Yeast Genetics and Molecular Bi-
ology.—The XXIII International Conference on Yeast Ge-
netics and Molecular Biology will be held July 1—6, 2007,
at Melbourne Convention Centre inMelbourne, Australia.
With speakers such as 2001 Nobel Prize winner Sir Paul
Nurse and Whitehead Member Gerry Fink already con-
ﬁrmed, the program is set to be a “not to be missed” event
on the scientiﬁc calendar. Symposia will address yeast
models for human disease and aging; regulation of gene
expression; genome stability and rearrangements; cell
growth, division, and differentiation; yeast biotechnol-
ogy; phylogeny and systematics; systems-level approaches
to understanding yeast; metabolism and metabolomics;
and compartmentation of cellular activities. Workshops
will address the topics of yeasts in brewing, wine, and
biotechnology; protein transport and turnover; mem-
brane proteins and lipids; other yeast and fungi as model
systems; the cytoskeleton; yeasts as pathogens: biology
and clinical concerns; posttranslationalmodiﬁcations and
proteomics; transcription and control of gene expression;
chromosomes: structure and inheritance; organelle divi-
sion and inheritance; cell signalling; yeast models for hu-
man disease and aging; bioinformatics and genomewide
studies; nuclear structure/organization; and new devel-
opments in methodologies and technologies. For more
information or to register for the conference, visit the con-
ference Web site (http://www.yeast2007.org/).
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Calls for Patients
Emory FMR1 Resequencing Project.—We have begun a Na-
tional Institutes of Health-sponsored study to uncover
conventional mutations of FMR1 in patients presenting
with aspects of fragile X syndrome but without repeat ex-
pansion mutations. We are seeking DNA samples from
such male patients who meet our inclusion criteria, for
complete, no-cost FMR1 reseqencing. Please visit the
Emory FMR1 Resequencing Project Web site (http://www
.fmr1resequencing.org/) for further information and in-
structions for sample submission. Other inquiries can be
directed to Dr. Stephen T. Warren by e-mail (swarren
@emory.edu).
Chromosome 22q11.2 Microdeletion/Microduplication Syn-
drome Encompassing the BCR Gene.—Patients with micro-
deletions or microduplications involving the BCR region
on chromosome 22q11.23 are being sought for partici-
pation in a research project. The goals of the project in-
cludes array CGH mapping of the chromosomal break-
points, determination of parental origin of the derivative
chromosome, and determination of the spectrum of clin-
ical abnormalities associated with microdeletions/micro-
duplications of varying size. It is expected that most eli-
gible patients will have been identiﬁed as having a BCR
microdeletion/microduplication by a FISH evaluation for
subtelomere rearrangements. A further description of the
project, forms for sample submission and patient/parent
consent, and contact information are available by con-
tacting Andrew J. Carroll, Ph.D. (acarroll@genetics.uab
.edu), or Fady Mikhail, M.D., Ph.D. (fmikhail@genetics
.uab.edu), by e-mail or by telephone at (205) 934-4968.
Call for Proposals
Angelman Syndrome Foundation Call for Research Propos-
als.—The Angelman Syndrome Foundation announces
the availability of $400,000 to be awarded in support of
research on Angelman syndrome. Angelman syndrome is
a neurodevelopmental disorder caused by a deﬁciency of
the ubiquitin protein ligase UBE3A in the brain. Appli-
cations related to any area of research involvingAngelman
syndrome will be considered; the highest priority will be
given to pilot projects testing new ideas about the path-
ogenesis of, therapy for, and educational best practices in
Angelman syndrome. Researchers from all countries are
encouraged to apply. One-year grants will be awarded for
amounts of up to $100,000. The application should in-
clude a cover letter; a one-page summary abstract of pro-
posed research; a proposal of up to ﬁve pages, including
hypothesis, background, methods, signiﬁcance of the pro-
posed research, and identiﬁcation of the primary inves-
tigator; a one-page detailed budget; and the curriculum
vitae of the applicant. No indirect costs will be allowed.
Proposals involving human or animal subjects must be
approved by the relevant institutional review boards be-
fore funding is released. The application deadline is June
15, 2007. Fifteen complete copies of each proposal, in-
cluding the cover letter, should be submitted to the An-
gelman Syndrome Foundation, 4255 Westbrook Drive,
Suite 216, Aurora, IL 60504. Questions about this an-
nouncement should be directed to Joseph Wagstaff, M.D.,
Ph.D.; telephone: (704) 355-6091; e-mail: joseph.wagstaff
@carolinashealthcare.org
